And all of that is at stake. Last question. When the insulin initiative was first announced, the state set aside $50 million for a manufacturing plant. We shifted last year with the legislature. We actually are using some of that money for our inhaler initiative in the public schools through Calex. And we made the determination with biocon that their existing facility in Virginia was more than adequate to provide enough manufactured product for the state of California. (26:35–26:45)
CLAIM
Asserts that funds were redirected to an inhaler initiative in public schools.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.